Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07801599
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07801599
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07801599. Randomized; quadruple masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage
- Acronym
- CHAIN3
- Condition
- Intracerebral Hemorrhage
- Condition
- Hypertension
- Intervention (Drug)
- Huayu Jiedu Formula (FTFY-919) Granules
- Intervention (Drug)
- Huayu Jiedu Formula (FTFY-919) Traditional Decoction
- Intervention (Drug)
- Placebo Granules
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
- Collaborator
- Guangdong Provincial Natural Science Foundation Management Committee
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07801599- Content hash
39aab02dec189416e44dd391dbaf68fb48c4a63674a86054a2f41af825380190